Teva announces FDA approval of Austedo® (deutetrabenazine) tablets for the treatment of tardive dyskinesia in adults
admin 5th September 2017 Uncategorised 0Teva Pharmaceutical Industries
More: Teva announces FDA approval of Austedo® (deutetrabenazine) tablets for the treatment of tardive dyskinesia in adults
Source: MDlinx